AngioPlex® OCT Angiography from ZEISS ushers in a new era of eye care with non-invasive imaging of retinal microvasculature—taking glaucoma and retinal disease management and treatment planning to the next level.1 By offering the industry’s most comprehensive tools for assessing and analyzing a range of pathologies, ZEISS provides a complete OCT Angiography (OCTA) solution.
Non-invasive, dyeless angiography
Unlike other OCTA technologies, ZEISS AngioPlex enables the visualization of both vascular and structural information from a single, non-invasive scan.
OCTA for Diabetic Retinopathy, Age-related Macular Degeneration, Glaucoma & more
OCT Angiography is known to reveal early indicators of many ocular diseases. ZEISS AngioPlex offers advanced care for patients suffering from vision loss due to diabetic retinopathy, glaucoma, AMD and other eye conditions.
Fast & Easy
AngioPlex image capture with Single Scan Simplicity and FastTrac™lets you scan at the highest resolution, minimizing artifacts from blinks and other eye movements, and without sacrificing patient throughput.
Manage your patients longer
According to a recent survey, majority of AngioPlex users have incorporated OCTA into their disease management protocol—AMD (90%), DR (88%) and diseases of the vasculature (85%). ZEISS AngioPlex is designed to support long-term patient management and guides clinicians on when to intervene or refer.
